This Blue State Made a Decision on Redistricting
And Here's Where Even Bill Maher's Audience Gasped When Talking About Graham Platner...
Fox News Contributor Outlines the Things That Must Happen With Trump's Iran Deal....
CNN's Fact-Checker Has Vanished
The NYT's 'Me Too' Reporter Ran Interference for Graham Platner This Week
US Iran Peace Deal Expected Within 24 Hours, Pakistan's Prime Minister Says
These Groups Used Taxpayer Funds to Push Leftist Causes – the Trump Administration...
Trump Says Iran Conflict Nears End As Deal Set for Sunday Signing
DOJ: Virginia Cannot Force Federal Agents to Reveal Their Identities
Will James Talarico Drop His Pedophile-Protecting Political Ally?
The Libs Are Already Being Insufferable Over the World Cup
Clinton-Appointed Activist Judge Blocks Ken Paxton's ActBlue Lawsuit to Protect James Tala...
Hillary Clinton Is Back and Lying Again
Treasury Is Right to Examine the National Security Risks of Foreign-Funded Lawsuits
The Algorithm Knows Where, Not Why
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement